FDA PMA
FDA Class 3
30-Day Notice Accepted
🇺🇸 United States
Implantable Cardioverter Defibrillator (Non-Crt)
PMA: P220012
·
Supplement: S024
·
Decision May 2, 2024
Classifications
1
FEI Numbers
49
Registration Numbers
49
Basic Information
- Device Name
- Implantable Cardioverter Defibrillator (Non-Crt)
- Trade Name
- Epsila EV Extravascular Lead
- PMA Number
- P220012
- Supplement Number
- S024
- Device Class
- FDA Class 3
- Product Code
- LWS
- Generic Name
- Implantable cardioverter defibrillator (non-CRT)
- Medical Specialty
- Unknown
- Advisory Committee
- Cardiovascular
- Decision
- 30-Day Notice Accepted
- Decision Code
- OK30
- Decision Date
- May 2, 2024
- Date Received
- May 1, 2024
- Supplement Type
- 30-Day Notice
- Supplement Reason
- Process Change - Manufacturer/Sterilizer/Packager/Supplier
- Expedited Review
- N
Advisory Committee Statement
an update to the cleaning process and solution at a critical supplier of lead components
Classifications
This FDA Pre-Market Approval entry is associated with 1 FDA classification via its product code.
| Product Code | Device Name | Device Class | Medical Specialty |
|---|---|---|---|
| LWS | Implantable Cardioverter Defibrillator (Non-Crt) | FDA class 3 | Unknown |